Imatinib dose escalation for chronic phase–chronic myelogenous leukaemia patients in primary suboptimal response to imatinib 400 mg daily standard therapy

التفاصيل البيبلوغرافية
العنوان:	Imatinib dose escalation for chronic phase–chronic myelogenous leukaemia patients in primary suboptimal response to imatinib 400 mg daily standard therapy
المؤلفون:	Rea, D^{Aff1, Aff2, IDleu200932_cor1}, Etienne, G^{Aff2, Aff3}, Corm, S^{Aff2, Aff4}, Cony-Makhoul, P^{Aff2, Aff5}, Gardembas, M^{Aff2, Aff6}, Legros, L^{Aff2, Aff7}, Dubruille, V^{Aff2, Aff8}, Hayette, S^{Aff2, Aff9}, Mahon, F-X^{Aff2, Aff3, Aff10}, Cayuela, J-M^{Aff2, Aff11}, Nicolini, F E^{Aff2, Aff12}
المصدر:	Leukemia. 23(6):1193-1196
قاعدة البيانات:	Springer Nature Journals

الوصف
تدمد:	08876924 14765551
DOI:	10.1038/leu.2009.32